TD ASSET MANAGEMENT INC - INOTEK PHARMACEUTICALS CORP ownership

INOTEK PHARMACEUTICALS CORP's ticker is ITEK and the CUSIP is 45780V102. A total of 58 filers reported holding INOTEK PHARMACEUTICALS CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 1.9%.

Quarter-by-quarter ownership
TD ASSET MANAGEMENT INC ownership history of INOTEK PHARMACEUTICALS CORP
ValueSharesWeighting
Q4 2016$251,000
-36.5%
41,200
-1.2%
0.00%
-100.0%
Q3 2016$395,000
+66.7%
41,700
+31.1%
0.00%
Q2 2016$237,000
-0.4%
31,800
-1.2%
0.00%
Q1 2016$238,000
-36.7%
32,200
-3.0%
0.00%
-100.0%
Q4 2015$376,000
-4.1%
33,200
-20.4%
0.00%0.0%
Q3 2015$392,00041,7000.00%
Other shareholders
INOTEK PHARMACEUTICALS CORP shareholders Q1 2016
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 2,627,790$5,256,0007.39%
FT Options LLC 477,763$956,0001.26%
Sio Capital Management, LLC 726,900$1,454,0000.81%
SENZAR ASSET MANAGEMENT, LLC 852,022$1,704,0000.43%
DAFNA Capital Management LLC 237,135$474,0000.40%
SPHERA FUNDS MANAGEMENT LTD. 401,764$804,0000.16%
DLD Asset Management, LP 439,500$870,0000.14%
Minerva Advisors LLC 64,759$126,0000.07%
SHEPHERD KAPLAN KROCHUK, LLC 36,000$72,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 96,435$193,0000.04%
View complete list of INOTEK PHARMACEUTICALS CORP shareholders